Literature DB >> 23376776

Nutrient deprivation induces the Warburg effect through ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase.

Ching-An Wu1, Yee Chao, Shine-Gwo Shiah, Wan-Wan Lin.   

Abstract

The Warburg effect is known to be crucial for cancer cells to acquire energy. Nutrient deficiencies are an important phenomenon in solid tumors, but the effect on cancer cell metabolism is not yet clear. In this study, we demonstrate that starvation of HeLa cells by incubation with Hank's buffered salt solution (HBSS) induced cell apoptosis, which was accompanied by the induction of reactive oxygen species (ROS) production and AMP-activated protein kinase (AMPK) phosphorylation. Notably, HBSS starvation increased lactate production, cytoplasmic pyruvate content and decreased oxygen consumption, but failed to change the lactate dehydrogenase (LDH) activity or the glucose uptake. We found that HBSS starvation rapidly induced pyruvate dehydrogenase kinase (PDK) activation and pyruvate dehydrogenase (PDH) phosphorylation, both of which were inhibited by compound C (an AMPK inhibitor), NAC (a ROS scavenger), and the dominant negative mutant of AMPK. Our data further revealed the involvement of ROS production in AMPK activation. Moreover, DCA (a PDK inhibitor), NAC, and compound C all significantly decreased HBSS starvation-induced lactate production accompanied by enhancement of HBSS starvation-induced cell apoptosis. Not only in HeLa cells, HBSS-induced lactate production and PDH phosphorylation were also observed in CL1.5, A431 and human umbilical vein endothelial cells. Taken together, we for the first time demonstrated that a low-nutrient condition drives cancer cells to utilize glycolysis to produce ATP, and this increases the Warburg effect through a novel mechanism involving ROS/AMPK-dependent activation of PDK. Such an event contributes to protecting cells from apoptosis upon nutrient deprivation.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376776     DOI: 10.1016/j.bbamcr.2013.01.025

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  52 in total

1.  MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation.

Authors:  Alberto Delaidelli; Gian Luca Negri; Asad Jan; Brandon Jansonius; Amal El-Naggar; Jonathan K M Lim; Debjit Khan; Htoo Zarni Oo; Christopher J Carnie; Marc Remke; John M Maris; Gabriel Leprivier; Poul H Sorensen
Journal:  Cell Death Differ       Date:  2017-06-02       Impact factor: 15.828

Review 2.  AMPK's double-faced role in advanced stages of prostate cancer.

Authors:  Faeze Gharibpoor; Sara Kamali Zonouzi; Sepideh Razi; Nima Rezaei
Journal:  Clin Transl Oncol       Date:  2022-07-04       Impact factor: 3.340

Review 3.  Targeting mitochondrial metabolism for metastatic cancer therapy.

Authors:  Antonino Passaniti; Myoung Sook Kim; Brian M Polster; Paul Shapiro
Journal:  Mol Carcinog       Date:  2022-06-20       Impact factor: 5.139

4.  Experimental paradigms revisited: oxidative stress-induced tRNA fragmentation does not correlate with stress granule formation but is associated with delayed cell death.

Authors:  Nasim Sanadgol; Lisa König; Aleksej Drino; Michaela Jovic; Matthias R Schaefer
Journal:  Nucleic Acids Res       Date:  2022-06-14       Impact factor: 19.160

Review 5.  Regulation of pyruvate metabolism in metabolic-related diseases.

Authors:  Nam Ho Jeoung; Chris R Harris; Robert A Harris
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

6.  Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors.

Authors:  E M Dunbar; B S Coats; A L Shroads; T Langaee; A Lew; J R Forder; J J Shuster; D A Wagner; P W Stacpoole
Journal:  Invest New Drugs       Date:  2013-12-03       Impact factor: 3.850

7.  5'-AMP-activated protein kinase (AMPK) supports the growth of aggressive experimental human breast cancer tumors.

Authors:  Keith R Laderoute; Joy M Calaoagan; Wan-Ru Chao; Dominc Dinh; Nicholas Denko; Sarah Duellman; Jessica Kalra; Xiaohe Liu; Ioanna Papandreou; Lidia Sambucetti; Laszlo G Boros
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

8.  Stimulating pyruvate dehydrogenase complex reduces itaconate levels and enhances TCA cycle anabolic bioenergetics in acutely inflamed monocytes.

Authors:  Xuewei Zhu; David Long; Manal Zabalawi; Brian Ingram; Barbara K Yoza; Peter W Stacpoole; Charles E McCall
Journal:  J Leukoc Biol       Date:  2020-01-02       Impact factor: 4.962

9.  Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.

Authors:  Nicole M A White; Daniel W Newsted; Olena Masui; Alexander D Romaschin; K W Michael Siu; George M Yousef
Journal:  Tumour Biol       Date:  2013-10-19

10.  Sirtuin 6 promotes transforming growth factor-β1/H2O2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence.

Authors:  Xin-Xia Feng; Jing Luo; Mei Liu; Wei Yan; Zhen-Zhen Zhou; Yu-Jia Xia; Wei Tu; Pei-Yuan Li; Zuo-Hua Feng; De-An Tian
Journal:  Cancer Sci       Date:  2015-03-09       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.